Patent · US Expired

Tripeptide amides that block viral infectivity and methods of use thereof

US6593455B2 · kind B2 · utility

0Cited by

29References

5Claims

0Family size

Assignee

TRIPEP AB · SE

Inventors

David van der Spoel · Uppsala, SE
Csaba Hetényi · Uppsala, SE
Ákos Végvári · Uppsala, SE
Stefan Höglund · Uppsala, SE
Jin-Lian Su · Markham, CA
Sarah Sandin-Reneby · Stockholm, SE
Laura Goobar-Larsson · Stockholm, SE
Anders Vahlne · Strömstad, SE

Key dates

Filing date	Aug 24, 2001
Grant date	Jul 15, 2003
Priority date	—
Expiry date	Aug 24, 2021

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S977/904
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Embodiments relate to the discovery that tripeptide amides, which correspond to viral capsid sequences, can be used to inhibit viral infection, including human immunodeficiency virus (HIV) infection. More specifically, medicaments comprising tripeptide amides and methods of using said compounds for the prevention and treatment of viral infection, such as HIV infection, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.